SCHEMBL4713243

SCHEMBL4713243

CCOC(=O)c1ccc(/C=C/c2ccccn2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
HTT P42858 2/20 0.51
PPARG P37231 1/20 0.50
ALDH1A1 P00352 2/20 0.49
PTGS1 P23219 1/20 0.48
PTGS2 P35354 1/20 0.48
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
ESR1 P03372 1/20 0.47
CA7 P43166 1/20 0.47
CA9 Q16790 1/20 0.47
ESR2 Q92731 1/20 0.47
CA14 Q9ULX7 1/20 0.47
SLC11A2 P49281 1/20 0.47
SNCA P37840 1/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
LMNA P02545 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4713246 1.00 NPC1 (0.53) NPC1RAB9AHTTPPARGALDH1A1
SCHEMBL708541 0.84 NPC1 (0.55) NPC1RAB9AALDH1A1PTGS1PTGS2
SCHEMBL510062 0.84 NPC1 (0.55) NPC1RAB9AALDH1A1PTGS1PTGS2
SCHEMBL9953407 0.84 PPARG (0.66) NPC1RAB9APPARGALDH1A1CA12
SCHEMBL8160762 0.84 PPARG (0.66) NPC1RAB9APPARGALDH1A1CA12
SCHEMBL9717146 0.83 CA1 (0.66) NPC1RAB9AHTTPPARGALDH1A1
SCHEMBL9717141 0.83 CA1 (0.66) NPC1RAB9AHTTPPARGALDH1A1
SCHEMBL10618582 0.83 CA1 (0.66) NPC1RAB9AHTTPPARGALDH1A1
SCHEMBL7562110 0.81 ALDH1A1 (0.47) NPC1RAB9APPARGALDH1A1CA12
SCHEMBL7562106 0.81 ALDH1A1 (0.47) NPC1RAB9APPARGALDH1A1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0998459-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2008-04-23 EP claimed
EP-0998459-A2 PYRIDINE DERIVATIVES Novartis AG (CH) 2000-05-10 EP claimed
WO-1999002497-A2 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 1999-01-21 WO claimed
EP-0998459-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2008-04-23 EP disclosed
US-6656957-B1 Marked and selective modulating, especially antagonistic, action at human metabotropic glutamate receptors (mGluRs); treatment of disorders such as epilepsy, cerebral ischemias, especially acute ischemias, spasticity etc. NOVARTIS AG (CH) 2003-12-02 US disclosed